Product Information
FT ALL DAY PAIN 220 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0673 per EA under NDC 70677113702. Its NADAC has been published 139 times since Feb 7, 2024.
FDA first approved this application on Jan 13, 1997.
Strength
220 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677113702
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA074661FDA Approved
1/13/1997
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for FT ALL DAY PAIN 220 MG CAPLET has been published 139 times since Feb 7, 2024, and over the history we have for it it has risen 7.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0673 per EA |
|---|---|
| All-time high | $0.0683 (Aug 12, 2026) |
| All-time low | $0.0567 (Apr 17, 2024) |
| 52-week high | $0.0683 |
| 52-week low | $0.0635 |
| Median price | $0.0642 |
| Average price | $0.0641 |
| Largest weekly change | +8.7% (May 22, 2024) |
| Weeks tracked | 139 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT ALL DAY PAIN 220 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for FT ALL DAY PAIN 220 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0673 per EA (NDC 70677113702), effective Sep 30, 2026.
How has the price of FT ALL DAY PAIN 220 MG CAPLET changed over time?
Over the history we have for it, the NADAC for FT ALL DAY PAIN 220 MG CAPLET has risen 7.7%. It has been tracked across 139 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for FT ALL DAY PAIN 220 MG CAPLET?
Since Feb 7, 2024, the NADAC for FT ALL DAY PAIN 220 MG CAPLET has ranged from a low of $0.0567 (Apr 17, 2024) to a high of $0.0683 (Aug 12, 2026), with a median of $0.0642 per EA.
Are there cheaper alternatives to FT ALL DAY PAIN 220 MG CAPLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALL DAY PAIN RLF 220 MG CAPLET, is $0.0551 per EA — about 18% below FT ALL DAY PAIN 220 MG CAPLET.
Who manufactures FT ALL DAY PAIN 220 MG CAPLET?
FT ALL DAY PAIN 220 MG CAPLET (NDC 70677113702) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.